CU
Christian Uhrich
Investments at M Ventures
Karlsruhe, Baden-Württemberg
Overview
Christian Uhrich is an Investment Director specializing in Biotechnology Investments at M Ventures, with a strong background in venture capital and entrepreneurship. He holds a leadership position overseeing investment strategies and has served on multiple boards of directors within the biotech industry.
Uhrich's career highlights include his role as Head of Strategy at M Ventures and his involvement on the boards of LabGenius, Indi Molecular, and other biotech companies, showcasing his expertise in business development and strategic decision-making in the field of biotechnology investments.
Work Experience
Investment Director, Biotechnology Investments
2021 - Current
Head of Strategy
2019 - 2021
Board Observer
2024
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Raised $165,000,000.00 from CRV, RA Capital Management, Pappas Capital, DCVC Bio, SoftBank Vision Fund, Pivotal bioVenture Partners, M Ventures, Surveyor Capital, Lux Capital and Neotribe Ventures.
Member Board of Directors
2024
Vizgen is a biotech company that develops solutions for next-generation spatially resolved, single-cell transcriptomics.
Raised $136,200,000.00 from ARCH Venture Partners, Northpond Ventures and Tao Capital Partners.
Board Observer
2024
Member Board of Directors
2023
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic.
Raised $13,300,000.00 from M Ventures, SABEY, Legend Capital and Asset Management Ventures (AMV).
Member Board of Directors
2023
Board Observer
2023
Member Board of Directors
2022
Member Board of Directors
2022
Board Observer
2022